Synapse - Alexander Drilon

Results (156)

MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking

Journal Article

Arcila, M. E.; Drilon, A.; Sylvester, B. E.; Lovly, C. M.; Borsu, L.; Reva, B.; Kris, M. G.; Solit, D. B.; Ladanyi, M.
Clinical Cancer Research (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Modern Pathology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas

Meeting Abstract

Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers

Meeting Abstract

Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history

Meeting Abstract

Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Cancer biology

Book Section

Drilon, A. E.; Glass, J. L.; Levine, R. L.
In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

Fulltext@MSK | Save

Unsuspected collision of synchronous lung adenocarcinomas: A potential cause of aberrant driver mutation profiles

Journal Article

Rekhtman, N.; Borsu, L.; Reva, B.; Arcila, M.; Riely, G. J.; Ladanyi, M.; Drilon, A.
Journal of Thoracic Oncology (2014)

Fulltext@MSK | Save

Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials

Meeting Abstract

Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers

Meeting Abstract

Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Alexander Edward Drilon

Results (156)

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Book Section

Journal Article

Meeting Abstract

Meeting Abstract